Aging
Navigate
Submit an Article
Research Paper|Volume 16, Issue 11|pp. 10074–10107
Immunotherapy, prognostic, and tumor biomarker based on pancancer analysis, SMARCD3
Back to articleFigure 1(1 of 6)
100%
Figure 1
Figure 1.Expression of SMARCD3 in pan-cancer. (A) Expression difference of SMARCD3 between tumor samples and normal tissue; (B) Ranking of SMARCD3 expression in pan-cancer.